NewEdge Advisors’s Chemed CHE Stock Holding History

NewEdge Advisors’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$974K	Buy	2,091 +2,042	+4,167%	+$859K	﹤0.01%	1687
2026 Q1	$18.5K	Hold	49	–	–	﹤0.01%	3215
2025 Q4	$21K	Sell	49 -41	-46%	-$17.8K	﹤0.01%	3242
2025 Q3	$40.3K	Sell	90 -47	-34%	-$21.3K	﹤0.01%	2891
2025 Q2	$66.7K	Hold	137	–	–	﹤0.01%	2578
2025 Q1	$84.3K	Hold	137	–	–	﹤0.01%	2353
2024 Q4	$72.6K	Hold	137	–	–	﹤0.01%	2391
2024 Q3	$82.3K	Buy	137 +25	+22%	+$14.2K	﹤0.01%	2259
2024 Q2	$60.8K	Buy	112 +38	+51%	+$21.8K	﹤0.01%	2285
2024 Q1	$47.5K	Sell	74 -509	-87%	-$309K	﹤0.01%	2331
2023 Q4	$348K	Buy	583 +565	+3,139%	+$316K	﹤0.01%	1478
2023 Q3	$9.36K	Hold	18	–	–	﹤0.01%	2592
2023 Q2	$9.75K	Hold	18	–	–	﹤0.01%	2605
2023 Q1	$9.68K	Sell	18 -16	-47%	-$8.16K	﹤0.01%	2577
2022 Q4	$8.18K	Buy	+34	New	+$16.6K	﹤0.01%	2433
2020 Q4	–	Sell	-1,105	Closed	-$531K	–	997
2020 Q3	$531K	Sell	1,105 -16	-1%	-$7.85K	0.02%	557
2020 Q2	$506K	Buy	+1,121	New	+$500K	0.02%	531

Other funds holding CHE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

NewEdge Advisors's CHE Position: Q2 2026 in Review

NewEdge Advisors increased its Chemed (CHE) stake by 4,167% in Q2 2026, buying an estimated $859K and bringing the position to 2,091 shares worth $974K. The position accounts for ﹤0.01% of the portfolio, ranked #1687.

NewEdge Advisors first reported a position in CHE in Q2 2020 and has held it in 17 quarters since. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

NewEdge Advisors held 2,091 shares of Chemed worth $974K as of Q2 2026.
NewEdge Advisors bought 2,042 Chemed shares in Q2 2026, an estimated $859K.
Chemed made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #1687 holding.
NewEdge Advisors first reported a position in Chemed in Q2 2020 and has held it in 17 quarters since.
532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.